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Edited by Vladimir SkulachevAbstract The change in the conformation of Bax at the onset of
apoptosis is a determinant for the execution of this cell death
programme. However, very few models can account for this mod-
iﬁcation and the factors involved in this process remain elusive.
We have analysed the modiﬁcations in the conformation induced
by a variation in pH using a cell-free assay. We show that a mod-
erate basic or acidic pH can induce apoptotic-like changes in the
conformation of Bax, such as the exposure of the N-terminal or
the BH3 domain. These changes in the conformation are associ-
ated with the binding of Bax to mitochondria and an enhanced
Bax homo- and oligomerisation. Our results suggest that varia-
tions in the pH, in a range consistent with that often observed
during apoptosis, are suﬃcient to trigger Bax translocation to
mitochondria and the subsequent release of apoptogenic factors
from this organelle.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Members of the Bcl-2 family are the ﬁnal regulators of apop-
tosis, one of the major cell death programmes, induced by a
variety of physiological situations and death inducers [1].
The pro-apoptotic protein Bax a (Bax) is normally contained
in an inactive conformation in healthy cells and its activation
during the early phases of apoptosis is associated with changes
in the conformation [2]. These changes involve not only the
unblocking of the addressing signal of Bax and the insertion
into the mitochondrial outer membrane, but also the subse-
quent oligomerisation step [3]. However, the structural
changes involved in the transition from a monomeric inactive
state to an oligomeric membrane-embedded conformation are
not completely understood [2]. It is likely that this importantAbbreviations: Bax, Bax a; cyt c, holocytochrome c; IP, immunopre-
cipitation; 35S-Met-Bax, in vitro translated Bax; RFP, red ﬂuorescence
protein
*Corresponding author. Fax: +33 240084082.
E-mail address: fval@nantes.inserm.fr (F.M. Vallette).
1 Present address: Memorial Sloan-Kettering Cancer Center, 1275
York Avenue, New York, NY 10021, USA.
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.10.080step is under the control of numerous physiological factors,
possibly of diﬀerent natures [4]. It has been proposed that pro-
teins like Bid, a BH3-only protein, play an important role in
the translocation of Bax from the cytosol to mitochondria by
inducing a change in the conformation and possibly chaperon-
ing Bax en route to the mitochondria [5].
Several in vitro studies have shown that variations in the pH
are often observed during the early steps of Bax activation and
it has been proposed that a rise or a fall in pH was required for
the activation of Bax [6–9]. However, MNR analysis of Bax
has shown that its 3-D structure is not sensitive to changes
in pH [10]; ruling out that the pH could be, at least directly,
involved in the physiological apoptotic process. Nonetheless,
a variation in pH has been shown to enhance the association
of Bax with mitochondria in a cell free assay and in vitro
[7,11]. In this study, we have investigated the eﬀect of the pH
on the diﬀerent steps of activation of Bax using a cell free assay
viz, the exposure of its N-terminal and BH3 domain, the
induction of its association with mitochondria and the forma-
tion of homo- or hetero-oligomers.2. Materials and methods
2.1. Reagents
Unless speciﬁed otherwise, all reagents used in this study were from
Sigma (St. Louis, MO, USA). Monoclonal Bax antibodies 2D2, AF820
and 6A7 were from R&D Systems (Lille, France) and the polyclonal
anti-Bax BH3 TL41 was obtained as described previously [12]. Anti-
cyt c antibody was from Pharmingen (#54854).
2.2. Association of Bax with mitochondria in the cell free assay
Mitochondria were prepared from normal rat liver and the cell-free
association of Bax with the mitochondria was performed as described
previously [11]. Brieﬂy, 35S-Met-proteins were synthesised from
cDNAs using the TNT coupled transcription/translation system from
Promega (Lyon, France). The post-translational insertion of in vitro
translated (IVT) proteins into mitochondrial membranes and the alka-
line treatment of mitochondrial-bound proteins were performed in a
standard import buﬀer as described previously [11]. 35S-Met-proteins
bound to the mitochondria were recovered in the pellet after centrifu-
gation for 10 min at 4 C at 8000 · g. 35S-Met-Bax associated with iso-
lated mitochondria was analysed in a 12% SDS–PAGE and scanned
with a Phosphorimager (Molecular Dynamics, France). The liberation
of cyt c induced by Bax was determined by anti-cyt c immunoblots of
the supernatant of the above cell free assay. The amount of protein
present in the gels was subsequently quantiﬁed using the IP-Lab gel
programme (Signal Analytics, Vienna, VA, USA).
2.3. Immunoprecipitation of Bax
For immunoprecipitation (IP) experiments, 35S-Met-Bax mutants
were incubated in the presence of Bax antibodies: 2D2, 6A7, Ab-4 or
AF820 for 1 h at 4 C. The antibody/protein complexes were thenblished by Elsevier B.V. All rights reserved.
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ugation and washes according to the manufacturers instructions
(Zymed, USA). Brieﬂy, IVT Bax was incubated at 4 C for 10 min with
10 ll non-immune IgG serum and 50 ll protein G–agarose. The mix-
ture was centrifuged for 10 min at 10000·g and the supernatant trans-
ferred to a new tube, to which 4 lg of Bax antibodies was added
together with the secondary antibodies (Sigma) coupled to either pro-
tein G– or protein A–agarose. After an additional incubation with agi-
tation of 1 h at 4 C, the mixture was centrifuged at 3000 · g for 2 min,
then washed several times in PBS before a ﬁnal centrifugation. Samples
were kept in SDS–PAGE loading buﬀer at 80 C for no more than 2
weeks before SDS–PAGE and autoradiography.2.4. Modiﬁcation of pH and trypsin treatment of Bax
The pH was, adjusted as described in [13,14] with NaOH or HCl.
Trypsin treatment of Bax was performed as described in [11], except
that, when Bax was incubated at various pH, the pH was adjusted
to 7.4 before proteolysis.2.5. Detection of the pH-induced homo- or oligomerisation of Bax
Low-binding Ultracel-YM membrane from Millipore (France) with
cut-oﬀs of 30 kDa (MicroCon YM 30) or 50 kDa (MicroCon YM 50)
was used to isolate IVT Bax monomers (20 kDa) or dimers (40 kDa),
respectively, as recommended by the manufacturer. IVT Bax incubated
at various pH were ﬁrst added to microCon YM 30 and the retained
fractions were reloaded on the microCon YM 50. The presence of
IVT Bax in the eluted fractions from both columns was veriﬁed by
SDS–PAGE and autoradiography.2.6. Oligomerisation of Bax with Bcl-2 and Bcl-xl
IVT Bax was incubated at diﬀerent pH. The association of Bax with
Bcl-2 and Bcl-xl was performed using puriﬁed His-tagged full-length
Bcl-2 or Bcl-xl as described by Cartron et al. [15,16], except that
IVT Bax was incubated at various pH prior to the addition of the
His-tagged anti-apoptotic proteins and binding to Ni–NTA agarose.Fig. 1. Inﬂuence of the pH on the interaction of Bax a with mitochondria in a
neutralisation at pH 7.4 and the addition of 50 lg rat liver mitochondria i
incubation (1 h at 37 C), the mitochondria were recovered by centrifugation
by ﬂuorography. In some cases before centrifugation, mitochondria were tr
analyses. i25% = 25% of the IVT Bax added. Histograms show the amount o
from at least four independent experiments. (B) Bax-induced release of cyt c
incubated above. Only membrane embedded (i.e., AT-resistant) IVT Bax c
representatives of at least three independent experiments. i50% = 50% of cytBound Bax/Bcl-2 or Bax/Bcl-xl complexes was eluted with 250 mM
imidazole [15,16] and the amount of Bax determined as described in
Section 2.2.2.7. Cross-linking
The cross linker DSS (N-hydroxysuccinimide ester) was added to
IVT Bax at a ﬁnal concentration of 5 mM in 1 ml. After incubation
for 30 min at room temperature, the cross-linker was quenched by
the addition of 1 M Tris–HCl (pH 7.5). Bax oligomerisation was ana-
lysed by 12% SDS–PAGE gels, followed by Phosphorimager analysis.
2.8. Confocal studies of Bax changes of conformation
Apoptosis was induced in human glioblastoma cell lines by 20 lM
staurosporine (STS), a broad range kinase inhibitor, as described in
[17]. Laser confocal microscopy was performed as described earlier
[17] using antibodies raised against diﬀerent Bax epitopes.3. Results
3.1. Change in pH triggers Bax association with mitochondria
IVT Bax was incubated in the presence of rabbit reticulocyte
at diﬀerent pH (from pH 4 to 10) for 30 min at 37 C. At the
end of the incubation, the pH was adjusted to 7.4 with NaOH
or HCl prior to incubation with mitochondria (see Section
2.2). As previously reported [11,16,18], at pH 7.4 Bax binds
poorly to mitochondria in the cell free assay and this is still
true when the pH was increased to pH 7.8 or decreased to
pH 6.8 (Fig. 1A). In all cases, none of the mitochondrial-
bound Bax a was membrane embedded as judged by its resist-
ance to an alkaline treatment. Conversely, at pH 8.2 or 6.0 Bax
binding to mitochondria was signiﬁcantly increased and most
of the protein was membrane embedded, indicating that Baxcell free assay. (A) 35S-Met-Bax was incubated at diﬀerent pH prior to
n standard import buﬀer as described in Section 2. At the end of the
and the presence of IVT Bax directly analysed on SDS–PAGE followed
eated with 100 mM Na2CO3 (pH 11) (alkaline treatment: AT) before
f IVT Bax present in the gels. Data shown are means ± S.D. obtained
was analysed by immunoblotting the supernatant from mitochondria
aused the release of cyt c for mitochondria. Experiments shown are
c present in 50 lg rat liver mitochondria.
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In the latter case and contrary to that observed with a Bax pre-
incubated at pH 6.8–7.8, cyt c was released from mitochon-
dria, demonstrating that a pretreatment at pH 8.2 or at pH
6.0 of Bax induced a functional change in the conformation
(Fig. 1B). As a control, we used a plasmid encoding for a cyto-
solic red ﬂuorescence protein (RFP) incubated at various pH.
As shown in Fig. 1B, under these conditions, no liberation of
cyt c was observed.
3.2. pH triggers two types of changes in the conformation of
Bax
The conformational changes induced by a variation in the
pH were analysed by IP of IVT Bax using diﬀerent antibodies
(Fig. 2A). The 2D2 antibody is directed against an N-terminal
peptide (amino acids 3–16) and cross-reacts with Bax regard-
less of its inactive/cytosolic or active/mitochondria conforma-
tion [19,20]. The anti-conformational antibody 6A7 directed
against amino acids 12–24 [19,20] and the antibodies AF820,
TL-41 and Ab-4, which are, respectively, directed against the
N-terminal amino acids 12–34, 57–69 (i.e., the BH3 domain)Fig. 2. Inﬂuence of pH on epitopes accessibility and sensitivity to a trypsin tre
diﬀerent antibodies used in this study as well as the diﬀerent Bax domains.
indicated by the manufacturers (see Section 2) and BH domains are illustra
diﬀerent pH before IP with diﬀerent antibodies, followed by SDS–PAGE/ﬂuo
with trypsin (1 mg/ml for 10 min at 4 C), then proteolysis was stopped by
denatured in SDS–PAGE buﬀer as described in [13]. Fluorographs illustrat
Schematic representation of the results obtained with epitopes accessibility (i.e
10 to 4. Shaded squares indicate a positive IP or resistance to trypsin trea
treatment.and 98–117 (i.e., the a5a6 helices). As illustrated in Fig. 2B,
a variation in the pH triggered selective IP with the diﬀerent
antibodies: exposure of the BH3 domain was induced in Bax
pretreated at a pH superior to 7.6 and inferior to 7.0, while
exposure of the N-terminus was observed only when 35S-
Met-Bax was incubated at a pH superior to 8.2 or inferior to
6.0. A change in the sensitivity of a protein towards mild pro-
teolysis is an indicator of structural modiﬁcation. As shown in
Fig. 2C, in the range of pH from 7.8 to 6.8, 35S-Met-Bax was
highly sensitive to trypsin proteolysis, while at a pH superior
to 8.2 or inferior to 6, it became resistant to trypsin. Of note,
similar results were obtained using proteinase K (data not
shown). Taken together (Fig. 2D), these results suggest that
two major changes in the conformation are induced by pH.
The ﬁrst occurred at a pH between 6.8 and 6 or between 7.6
and 8, in which the BH3 domain of Bax became accessible
to antibody binding. The second occurred at a pH inferior to
6 or superior to 8, as observed by its resistance to a trypsin
treatment and by IP using antibodies directed against the N-
terminus and the helix a5. Thus, from these data one can con-
clude that the ﬁrst step in the change in the conformation ofatment. (A) Schematic representation of the epitopes recognised by the
Localisation of the epitopes recognised by the diﬀerent antibodies as
ted as described by Suzuki et al. [10]. (B) IVT Bax was incubated at
rography analysis as described in Section 2. (C) IVT Bax was incubated
the addition of 10 mg/ml soybean trypsin inhibitor and immediately
ed are representatives of at least three independent experiments. (D)
., IP) and trypsin resistance of IVT Bax incubated at diﬀerent pH from
tment, while the clear squares indicate no IP or sensitivity to trypsin
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tion of the N-terminal, which contains its addressing signal [17]
and the helix a1, part of the putative pore-forming domain
that has been shown to be the membrane insertion domain
of Bax a [21].
To address the physiological signiﬁcance of these ﬁndings,
we used laser confocal microscopy to study the time course
of the appearance of Bax epitopes in human glioma cells trea-
ted with 2 lM STS. As illustrated in Fig. 3, the 2D2 antibody
recognises both the mitochondrial and the cytosolic fractions
of Bax. We observed that most of the cytosolic Bax was trans-
located to mitochondria after 5 h and that this subcellular
localisation was accompanied by the exposure of the 6A7 epi-
topes [19]. In agreement with our results with pH, the exposure
of the BH3 epitope (i.e., labelling with TL41) occurred before
that of the N-terminus (i.e., labelling with 6A7) (Fig. 3).3.3. Shift to low or high pH triggers Bax homo- and
hetero-oligomerisation
Xie et al. [8] showed that an acidic pH promoted the dime-
risation among Bcl-2 family proteins. We investigated Bax
homo-dimerisation using a simple experimental setting in
which Bax monomer was separated from the dimers by simple
ﬁltration using MicroCon ﬁlters with diﬀerent cut-oﬀs (see Sec-
tion 2.4 and Fig. 4A). As shown in gel ﬁltration experiments, at
pH 7.4, Bax was present in the eluant of MicroCon YM-30 and
was not detectable in the fraction retained by MicroCon YM-
30 (data not shown). This result suggested that it was present
solely in a molecular weight inferior to 30 kDa and, thus, most
probably as a monomer (Fig. 4B). Conversely, when Bax was
preincubated at pH 8.2, it was retained in the MicroCon YM-
30 but eluted from the MicroCon YM-50, suggesting that this
pH induced dimerisation. The speciﬁcity of this technique was
assessed using a Bax mutant (Bax K64E) that is unable to
dimerise (Cartron et al., in preparation). At pH 7.4 or 8.2,
Bax K64E was detected only in the eluted fractions of the Mic-
roCon YM-30 (Fig. 4B), conﬁrming that this construct did not
undergo homo-dimerisation.Fig. 3. Confocal analysis of the change of conformation of Bax. Human glio
the anti-Bax antibodies 6A7, 2D2 and TL41 every hour over a period of tim
antibody was observed throughout this period of time, while labelling with TL
is representative of at least ﬁve diﬀerent experiments.To conﬁrm the pH induced-dimerisation, IVT Bax or Bax
K64E were cross-linked using DSS and the cross-linked prod-
ucts were analyzed on SDS–PAGE and autoradiography as
described in Section 2. As shown in Fig. 4C, the molecular
weights of the cross-linked products were consistent with our
previous experiment and show a BH3-dependent pH-induced
dimerisation.
Next, we investigated the eﬀect of the pH on the formation of
hetero-dimers between Bax and Bcl-xl or Bcl-2. Since Bax can
form hetero-dimers with Bcl-2 and Bcl-xl at pH 7.4, we did
not use the ﬁltration on MicroCon, as it is essentially a qualita-
tive method. Instead, we analysed the pH-induced dimerisation
of Bax with His-tagged Bcl-2 or Bcl-xl using a method previ-
ously reported [16], as it allowed a quantitative evaluation of
the association of Bax with anti-apoptotic proteins [15]. As
shown in Fig. 4D, increasing the pH from 7.4 to 8.2 or decreas-
ing it from 7.4 to 6.0 similarly enhanced the binding of Bax to
both Bcl-2 and Bcl-xl. In this case, since the increase of hetero-
oligomerisation was observed at pH 7.8, we concluded that
the conformational constraint required for the binding of Bax
with Bcl-2 or Bcl-xl was diﬀerent from that required for its
homodimerisation. Of note, Bax K64E did not oligomerise with
either Bcl-2 or Bcl-xl under these conditions.4. Discussion
The alkalisation of the intracellular compartment has been
shown to induce Bax translocation in vitro in diﬀerent types
of cells and by diﬀerent apoptotic stimuli [6,7,9]. From these
results, a model has been elaborated wherein the intramolecu-
lar interactions of the N-terminus and the C-terminus of Bax,
which secured its ‘‘inactive’’ state, could be altered by modiﬁ-
cation of the pH [7]. This modiﬁcation can be either an acidi-
ﬁcation or an alkalisation as shown by Khaled et al. [7] that
both positively and negatively charged amino acids could be
involved in the pH-induced conformational change. We used
diﬀerent antibodies which recognise diﬀerent epitopes in Baxma cells [23] were treated with 20 lM STS, then Bax was labelled with
e of 8 h. As illustrated in this ﬁgure, the labelling with the anti-2D2
41 and 6A7 was observed, respectively, after 4 and 5 h. The illustration
Fig. 4. pH-induced homo- and hetero-oligomerisation of Bax. (A) Schematic representation of the experimental settings used to analyse homo-
dimerisation of Bax. IVT Bax or Bax K64E [1] was ﬁltered through MicroCon YM as described in Section 2. According to the cut-oﬀ, only
monomers can be recovered with MicroCon YM-30 [2]. Samples not ﬁltered through MicroCon YM-30 (thus, with a molecular weight superior to 30
kDa) were reloaded on a MicroCon YM-50 and the presence of Bax analysed in ﬁltrated fraction [3]. The fraction of Bax not ﬁltered through
MicroCon YM-30 but ﬁltrated on MicroCon YM-50 is thus likely to be a dimer (i.e., molecular weight P 30 kDa and 650 kDa). Larger oligomers
or aggregates, however, were not observed in the fraction retained on MicroCon YM 50 (data not shown). Thus, the absence of Bax in the second
ﬁltration (i.e., MicroCon YM-50) means that all the Bax was present as a monomer. (B) IVT Bax or Bax K64E [1], incubated at two pH (i.e., pH 7.4
and 8.2), ﬁltered through MicroCon YM-30 [2] and MicroCon YM-50 [3]. Since 35S-Met-Bax (Bax) or Bax K64E was eluted in a large volume (about
500 ll), Bax was immunoprecipitated, as described in Section 2, with the 2D2 antibody (IP-Bax) or with non-immune IgG, as a control for non-
speciﬁc IP (IP-IgG). Autoradiography shown is representative of 3 independent experiments. (C) IVT Bax and Bax K64E were cross-linked at pH 7.4
or 8.2 and their molecular weight analysed on SDS–PAGE and autoradiography as described in Section 2. M = monomer, MW 21 kDa; D = dimer,
MW 42 kDa. (D) The amount of IVT Bax oq Ban K64E associated with His-tagged Bcl-xl or Bcl-2 was determined as described in Section 2. Data
are means ± S.D., calculated from at least three independent experiments.
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conformation induced by pH (Fig. 2A). We show that the 2D2
antibody immunoprecipitated Bax at all pH studied, while the6A7 antibody recognises this protein only at pH superior to 8.6
or inferior to 6.8 (Fig. 2B). These diﬀerent sensitivities can be
related to a change of conformation involving a sequence
46 P.F. Cartron et al. / FEBS Letters 578 (2004) 41–46encompassing amino-acids 12-24 (i.e., the 6A7 epitope) which
is hidden at neutral pH as originally proposed [20]. Our results
are completely in agreement with the above model as we show
that a transient incubation of Bax at acidic or basic pH is suf-
ﬁcient to trigger irreversible changes in the conformation con-
sistent with that observed during apoptosis as the monoclonal
antibody 2D2 recognises Bax both in resting and in apoptotic
cells, while the monoclonal antibody 6A7 and the polyclonal
antibody TL41 recognised Bax only in apoptotic cells (Fig.
3). However, MNR studies have shown that shifting the pH
from 6 to 8 did not signiﬁcantly aﬀect the structure and the
oligomerisation state of Bax [10], contrary to experimental
data reported here and elsewhere [8]. The reason for this dis-
crepancy is unclear but it might reﬂect the fact that the confor-
mation of Bax analysed by Suzuki et al. [10] is only partial.
Indeed, the structure of the ﬁrst 12 amino acids of the protein,
which play an essential role in apoptosis [16,18] could not be
resolved by Suzuki et al. [10]. It is also possible that the puri-
ﬁcation procedure after expression in the bacteria induced a
conformation that could not be altered any further.
It has been reported that the exposure of internal region of
Bak, another pro apoptotic multidomain protein of the
BCl-2 family, was a secondary step and was preceded by the
exposure of the NT [22]. Here, we show that changes of
conformation of Bax follow a diﬀerent route as STS induced
apoptosis promotes ﬁrst the exposure of the BH3 domain of
Bax and as a secondary step that of Ha1 (Fig. 3). These diﬀer-
ences could be related to the fact that Bax change of conforma-
tion accompanies a change of subcellular localisation contrary
to Bak which is a mitochondria protein.
The exact impact of the pH on Bax function during in vivo
apoptosis still remains to be established. However, we show in
this work that simple shifts in the pH, compatible with that ob-
served in a cellular model, can reproduce in a cell free assay
some of the essential steps involved in Bax activation during
apoptosis: viz. exposition of the BH3 domain, the N-terminal
conformational epitope 6A7 and that of the helix a1. Quite
remarkably, the variations in the pH, which promote Bax
addressing to mitochondria in a cell free assay (Fig. 1), also
provoke its homo- or hetero-oligomerisation (Fig. 4), suggest-
ing that these events could occur in parallel in vivo but do not
necessarily involve mitochondrial elements. In conclusion,
studies on the conformational changes in Bax induced by the
pH could allow a better understanding of the energy required
and/or the domain(s) involved in Bax translocation and inte-
gration within the mitochondria.
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